In these experiments, the divergent responses of three melanoma cell lines to exosomes from sleep apnea patients before and after treatment indicated that STK11 gene mutations in melanoma cells make them particularly responsive to sleep apnea by altering cellular metabolism, and that specific microRNAs appear to underlie such effects. The gene discussed is STK11; the disease is melanoma.